摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-乙酰基-5’-O-(4,4-二甲氧基三苯甲基)-2’-O-甲基胞苷-3’-(2-氰基乙基-N,N-二异丙基)亚磷酰胺 | 199593-09-4

中文名称
N-乙酰基-5’-O-(4,4-二甲氧基三苯甲基)-2’-O-甲基胞苷-3’-(2-氰基乙基-N,N-二异丙基)亚磷酰胺
中文别名
N-乙酰基-5'-O-(4,4-二甲氧基三苯甲基)-2'-O-甲基胞苷-3'-(2-氰基乙基-N,N-二异丙基)亚磷酰胺;2'-OMe-Ac-C亚磷酰胺单体;N-乙酰基-5`-O-(4,4-二甲氧基三苯甲基)-2`-O-甲基胞苷-3`-(2-氰基乙基-N,N-二异丙基)亚磷酰胺;2'-OME-AC-C亚磷酰胺单体;2-O-ME-RC(AC)亚磷酰胺单体
英文名称
2'-OMe-Ac-C Phosphoramidite
英文别名
N-[1-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-3-methoxyoxolan-2-yl]-2-oxopyrimidin-4-yl]acetamide
N-乙酰基-5’-O-(4,4-二甲氧基三苯甲基)-2’-O-甲基胞苷-3’-(2-氰基乙基-N,N-二异丙基)亚磷酰胺化学式
CAS
199593-09-4;213020-84-9;213020-85-0
化学式
C42H52N5O9P
mdl
——
分子量
801.877
InChiKey
WNWUMIPFLOKTEZ-UAQIPLLRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    102 - 104°C
  • 溶解度:
    可溶于DMSO(少许)、甲醇(少许)

计算性质

  • 辛醇/水分配系数(LogP):
    4.7
  • 重原子数:
    57
  • 可旋转键数:
    19
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    153
  • 氢给体数:
    1
  • 氢受体数:
    11

安全信息

  • 安全说明:
    S24/25
  • WGK Germany:
    3
  • 海关编码:
    29349990
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H315,H319,H335

SDS

SDS:f57c783a29d2100c66b37637a69f7e12
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-乙酰基-5’-O-(4,4-二甲氧基三苯甲基)-2’-O-甲基胞苷-3’-(2-氰基乙基-N,N-二异丙基)亚磷酰胺甲胺 作用下, 以 四氢呋喃 为溶剂, 反应 1.0h, 以90%的产率得到5'-O-dimethoxytritil-2'-O-methylcytidine-3'-O-(2-cianoethyl-N,N-diisopropylphosphoramidite)
    参考文献:
    名称:
    O-Selective Condensation Using P−N Bond Cleavage in RNA Synthesis without Base Protection
    摘要:
    In RNA synthesis without base protection, a new method for O-selective condensation with more than 99% selectivity was developed by 6-nitro-HOBt-mediated cleavage of undesired P(III)-N bonds on nucleobase moieties. Moreover, we for the first time succeeded in synthesizing oligoRNAs without base protection.
    DOI:
    10.1021/ol800911b
  • 作为产物:
    参考文献:
    名称:
    Ultrafast Cleavage and Deprotection of Oligonucleotides Synthesis and Use of CAcDerivatives
    摘要:
    We have investigated the use of alkylamines as fast cleavage and deprotection reagents for the solid phase synthesis of oligonucleotides and found methylamine/ammonium hydroxide (or methylamine) as an efficient reagent. The transamination side product formed with the commonly used dC(bz) has been eliminated by the use of dC(Ac) phosphoramidite. This system has successfully been used in the synthesis of oligonucleotides and oligonucleoside phosphorothioates. DMT dC(Ac) hydrogen phosphonate and DMT ribo C-Ac-2'-OMe phosphoramidite also have been prepared and used in the synthesis of oligonucleotides.
    DOI:
    10.1080/07328319708006236
点击查看最新优质反应信息

文献信息

  • MODIFIED DOUBLE-STRANDED POLYNUCLEOTIDE
    申请人:Koizumi Makoto
    公开号:US20120220649A1
    公开(公告)日:2012-08-30
    The present invention provides a double-stranded polynucleotide having a sense strand polynucleotide consisting of a nucleotide sequence complementary to a target sequence in a target gene, and an antisense strand polynucleotide having a nucleotide sequence complementary to the sense strand polynucleotide, wherein an aryl or heteroaryl compound is bound to a phosphate group at the 5′-end of the antisense strand polynucleotide.
    本发明提供了一种双链聚核苷酸,其具有一个具有与目标基因中的目标序列互补的核苷酸序列的正链聚核苷酸,以及一个具有与正链聚核苷酸互补的核苷酸序列的反义链聚核苷酸,其中一种芳基或杂环芳基化合物结合到反义链聚核苷酸的5'-末端的磷酸基团上。
  • Modified Single-Stranded Polynucleotide
    申请人:Koizumi Makoto
    公开号:US20130253038A1
    公开(公告)日:2013-09-26
    It is intended to provide a polynucleotide that is resistant to RNase and has an RNA interference effect, etc. The present invention provides a single-stranded polynucleotide that is derived from a double-stranded polynucleotide comprising a sense strand polynucleotide corresponding to a target gene, and an antisense strand polynucleotide having a nucleotide sequence complementary to the sense strand polynucleotide, and has a structure in which the 5′-end of the antisense strand and the 3′-end of the sense strand are linked via a phenyl group-containing linker to form a phosphodiester structure at each of these ends.
    本发明旨在提供一种对RNase具有抗性并具有RNA干扰效应的多核苷酸。本发明提供了一种单链多核苷酸,其源自于包含与目标基因相对应的正义链多核苷酸和具有与正义链多核苷酸互补的核苷酸序列的反义链多核苷酸的双链多核苷酸,且具有一种结构,其中反义链的5'-末端和正义链的3'-末端通过含苯基的连接剂连接形成磷酸二酯结构。
  • iRNA agents targeting VEGF
    申请人:Alnylam Pharmaceuticals, Inc.
    公开号:EP2365077A1
    公开(公告)日:2011-09-14
    The features of the present invention relate to compounds, compositions and methods useful for modulating the expression of vascular endothelial growth factor (VEGF), such as by the mechanism of RNA interference (RNAi). The compounds and compositions include iRNA agents that can be unmodified or chemically modified.
    本发明的特征涉及用于调节血管内皮生长因子(VEGF)表达的化合物、组合物和方法,例如通过 RNA 干扰(RNAi)机制。这些化合物和组合物包括可未经修饰或经化学修饰的 iRNA 制剂。
  • MODIFIED SINGLE-STRAND POLYNUCLEOTIDE
    申请人:Daiichi Sankyo Company, Limited
    公开号:EP2647713A1
    公开(公告)日:2013-10-09
    It is intended to provide a polynucleotide that is resistant to RNase and has an RNA interference effect, etc. The present invention provides a single-stranded polynucleotide that is derived from a double-stranded polynucleotide comprising a sense strand polynucleotide corresponding to a target gene, and an antisense strand polynucleotide having a nucleotide sequence complementary to the sense strand polynucleotide, and has a structure in which the 5'-end of the antisense strand and the 3'-end of the sense strand are linked via a phenyl group-containing linker to form a phosphodiester structure at each of these ends.
    本发明旨在提供一种能抗 RNase 并具有 RNA 干扰作用的多核苷酸等。本发明提供了一种由双链多核苷酸衍生的单链多核苷酸,双链多核苷酸包括与靶基因相对应的有义链多核苷酸和具有与有义链多核苷酸互补的核苷酸序列的反义链多核苷酸、其结构是反义链的 5'-端和有义链的 3'-端通过含苯基的连接体连接,在这两端分别形成磷酸二酯结构。
  • IRNA agents targeting VEGF
    申请人:Fougerolles De Antonin
    公开号:US20060223770A1
    公开(公告)日:2006-10-05
    The features of the present invention relate to compounds, compositions and methods useful for modulating the expression of vascular endothelial growth factor (VEGF), such as by the mechanism of RNA interference (RNAi). The compounds and compositions include iRNA agents that can be unmodified or chemically-modified.
    本发明的特征涉及用于调节血管内皮生长因子(VEGF)表达的化合物、组合物和方法,例如通过 RNA 干扰(RNAi)机制。本发明的化合物和组合物包括未经修饰或化学修饰的 iRNA 制剂。
查看更多

同类化合物

(3-三苯基甲氨基甲基)吡啶 非马沙坦杂质1 隐色甲紫-d6 隐色孔雀绿-d6 隐色孔雀绿 隐色乙基结晶紫 降钙素杂质10 重氮四苯基乙烷 酸性黄117 酸性蓝119 酚酞啉 酚酞二硫酸钾水合物 萘,1-甲氧基-3-甲基 苯酚,4-(1,1-二苯基丙基)- 苯甲醇,4-溴-a-(4-溴苯基)-a-苯基- 苯甲醇,2-氨基-5-氯-a-乙烯基-a-苯基- 苯甲酸,4-(羟基二苯甲基)-,甲基酯 苯甲酸,3-[[2-[[(1,1-二甲基乙氧基)羰基]氨基]-3-[(三苯代甲基)硫代]丙基]氨基]-,(R)- 苯甲基N-[(2(三苯代甲基四唑-5-基-1,1联苯基-4-基]-甲基-2-氨基-3-甲基丁酸酯 苯基双-(对二乙氨基苯)甲烷 苯基二甲苯基甲烷 苯基二[2-甲基-4-(二乙基氨基)苯基]甲烷 苯基{二[4-(三氟甲基)苯基]}甲醇 苯基-二(2-羟基-5-氯苯基)甲烷 苄基2,3,4-三-O-苄基-6-O-三苯甲基-BETA-D-吡喃葡萄糖苷 苄基 5-氨基-5-脱氧-2,3-O-异亚丙基-6-O-三苯甲基呋喃己糖苷 苄基 2-乙酰氨基-2-脱氧-6-O-三苯基-甲基-alpha-D-吡喃葡萄糖苷 苄基 2,3-O-异亚丙基-6-三苯甲基-alpha-D-甘露呋喃糖 苄基 2,3,4-三-O-(苯基甲基)-6-O-(三苯基甲基)-ALPHA-D-吡喃甘露糖苷 芴甲氧羰基-4-叔丁酯-天冬酰胺-S-三氯苯甲基-L-半胱氨酸 膦酸,1,2-乙二基二(磷羧基甲基)亚氨基-3,1-丙二基次氮基<三价氮基>二(亚甲基)四-,盐钠 脱氢奥美沙坦-2三苯甲基奥美沙坦脂 美托咪定杂质28 绿茶提取物茶多酚陕西龙孚 结晶紫 磺基琥珀酰亚胺基-4-[2-(4,4-二甲氧基三苯甲基)]丁酸酯 磷,三(4-甲氧苯基)甲基-,碘化 碱性蓝 硫代硫酸氢 S-[2-[(3,3,3-三苯基丙基)氨基]乙基]酯 盐酸三苯甲基肼 白孔雀石绿-d5 甲酮,(反-4-氨基-4-甲基环己基)-4-吗啉基- 甲基三苯基甲基醚 甲基6-O-(三苯基甲基)-ALPHA-D-吡喃甘露糖苷三苯甲酸酯 甲基3,4-O-异亚丙基-6-O-三苯甲基-beta-D-吡喃半乳糖苷 甲基3,4-O-异亚丙基-2-O-甲基-6-O-三苯甲基吡喃己糖苷 甲基2-甲基-N-{[4-(三氟甲基)苯基]氨基甲酰}丙氨酸酸酯 甲基2,3,4-三-O-苯甲酰基-6-O-三苯甲基-ALPHA-D-吡喃葡萄糖苷 甲基2,3,4-三-O-苄基-6-O-三苯甲基-ALPHA-D-吡喃葡萄糖苷 甲基2,3,4-三-O-(苯基甲基)-6-O-(三苯基甲基)-ALPHA-D-吡喃半乳糖苷